Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glufosfamide plus Gemcitabine in Advanced Solid Tumors and Pancreatic Cancer
NCT00102752Phase 2Completed
- Sponsor
- Threshold Pharmaceuticals
- Start
- Dec 2004
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of glufosfamide in solid tumor, pancreatic adenocarcinoma (PDAC), sponsored by Threshold Pharmaceuticals. Started Dec 2004; status: completed.
02
Drugs
glufosfamide
03
Conditions
solid tumorpancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00102752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102752.